Hepatitis D, Chronic: Clinical Trials

2 trials for Hepatitis D, Chronic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 2
Phase 21Recruiting 1

Follow Hepatitis D, Chronic: new trials by email Literature Review of Hepatitis D, Chronic trials Research Report on Hepatitis D, Chronic

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection
HepB mAb19 - Hepatitis D, Chronic, Hepatitis B Chronic Infection
Phase 1RecruitingAarhus University Hospital152026-04-232026-05-28
Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
GS-4321, GS-4321 Placebo - Chronic Hepatitis Delta
Phase 1 / Phase 2RecruitingGilead Sciences2002025-07-312026-08-27

Broader conditions

Chronic Disease (2)  ·  Digestive System Diseases (2)  ·  Disease Attributes (2)  ·  Hepatitis (2)  ·  Hepatitis D (2)  ·  Hepatitis, Chronic (2)  ·  Hepatitis, Viral, Human (2)  ·  Infections (2)  ·  Liver Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  RNA Virus Infections (2)  ·  Virus Diseases (2)

Sponsors

Aarhus University Hospital (1)  ·  Gilead Sciences (1)

Countries

Germany (2)  ·  Bulgaria (1)  ·  Denmark (1)  ·  Italy (1)  ·  Moldova (1)  ·  Romania (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

NIH funding

2025 (2)